25 September 2023
Sidley Advises on the Hong Kong IPO of Wuhan YZY Biopharma Co., Ltd.
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Meng Ding Lead | Sidley | Partner | Not stated | Not stated |
| Claudia Yu Lead | Sidley | Partner | Not stated | Not stated |
| Dennis Chan | Sidley | Senior associate | Not stated | Not stated |
| Cindy Liu | Sidley | Associate | Not stated | Not stated |
| Yiming Chen | Sidley | Associate | Not stated | Not stated |
| Zoe Yang | Sidley | Other | Not stated | Not stated |
| Freddie Feng | Sidley | Other | Not stated | Not stated |
| Sia Yang | Sidley | Other | Not stated | Not stated |
| Andy Tam | Sidley | Other | Not stated | Not stated |
| Yinfeng Zhang | Sidley | Other | Not stated | Not stated |
Stated terms
- Stated value
- USD 22.4m (US$ 22.4 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Wuhan YZY Biopharma Co., Ltd. (Issuer)
China Securities (International) Corporate Finance Company Limited (Underwriters)